Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000796921 | SCV000936456 | uncertain significance | Immunodeficiency 14 | 2024-01-03 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 15 of the PIK3CD gene. It does not directly change the encoded amino acid sequence of the PIK3CD protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs201785210, gnomAD 0.005%). This variant has been observed in individual(s) with clinical features of PIK3CD-related conditions (PMID: 36703223). ClinVar contains an entry for this variant (Variation ID: 643256). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Al Jalila Children’s Genomics Center, |
RCV002477815 | SCV002774982 | uncertain significance | not provided | 2022-12-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501056 | SCV002779716 | uncertain significance | Combined immunodeficiency with faciooculoskeletal anomalies; Immunodeficiency 14; Immunodeficiency 14b, autosomal recessive | 2021-12-17 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002477815 | SCV005186411 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Al Jalila Children’s Genomics Center, |
RCV000796921 | SCV001984325 | uncertain significance | Immunodeficiency 14 | 2020-11-22 | flagged submission | clinical testing |